PRVA Privia Health Group, Inc.

Nasdaq priviahealth.com


$ 24.77 $ 0.46 (1.89 %)    

Monday, 03-Nov-2025 15:59:51 EST
QQQ $ 622.99 $ 0.00 (0 %)
DIA $ 469.32 $ 0.00 (0 %)
SPY $ 675.63 $ 0.00 (0 %)
TLT $ 89.94 $ 0.00 (0 %)
GLD $ 367.45 $ 0.00 (0 %)
$ 24.76
$ 24.37
$ 0.00 x 0
$ 28.20 x 2
-- - --
$ 18.51 - $ 26.49
991,273
na
3.04B
$ 0.75
$ 204.76
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 02-27-2025 01-01-1970 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 02-27-2024 12-31-2023 10-K
8 11-03-2023 09-30-2023 10-Q
9 08-03-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 03-01-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-11-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 03-25-2022 12-31-2021 10-K
16 11-08-2021 09-30-2021 10-Q
17 08-09-2021 06-30-2021 10-Q
18 05-28-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 barclays-maintains-equal-weight-on-privia-health-gr-raises-price-target-to-22

Barclays analyst Andrew Mok maintains Privia Health Gr (NASDAQ:PRVA) with a Equal-Weight and raises the price target from $2...

 privia-health-acquires-evolents-aco-business-to-boost-value-based-care

Privia Health (PRVA) to acquire Evolent Health's (EVH) ACO business for $100M, expanding its value-based care footprint.

 stephens--co-reiterates-overweight-on-privia-health-gr-maintains-32-price-target

Stephens & Co. analyst Jeff Garro reiterates Privia Health Gr (NASDAQ:PRVA) with a Overweight and maintains $32 price ta...

 stephens--co-reiterates-overweight-on-privia-health-gr-maintains-32-price-target

Stephens & Co. analyst Jeff Garro reiterates Privia Health Gr (NASDAQ:PRVA) with a Overweight and maintains $32 price ta...

 jmp-securities-maintains-market-outperform-on-privia-health-gr-raises-price-target-to-30

JMP Securities analyst David M. Scharf maintains Privia Health Gr (NASDAQ:PRVA) with a Market Outperform and raises the pric...

 piper-sandler-maintains-overweight-on-privia-health-gr-lowers-price-target-to-35

Piper Sandler analyst Sean Wieland maintains Privia Health Gr (NASDAQ:PRVA) with a Overweight and lowers the price target fr...

 privia-health-gr-affirms-fy2025-sales-guidance-of-1800b-1900b-vs-3242b-est

Privia Health Gr (NASDAQ:PRVA) affirms FY2025 sales outlook from $1.800 billion-$1.900 billion to $1.800 billion-$1.900 billion...

 privia-health-gr-q2-adj-eps-024-beats-005-estimate-sales-521153m-miss-800104m-estimate

Privia Health Gr (NASDAQ:PRVA) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $0.0...

 evercore-isi-group-maintains-outperform-on-privia-health-gr-lowers-price-target-to-28

Evercore ISI Group analyst Elizabeth Anderson maintains Privia Health Gr (NASDAQ:PRVA) with a Outperform and lowers the pric...

 jp-morgan-maintains-overweight-on-privia-health-gr-raises-price-target-to-32

JP Morgan analyst Lisa Gill maintains Privia Health Gr (NASDAQ:PRVA) with a Overweight and raises the price target from $29 ...

 barclays-maintains-equal-weight-on-privia-health-gr-raises-price-target-to-24

Barclays analyst Andrew Mok maintains Privia Health Gr (NASDAQ:PRVA) with a Equal-Weight and raises the price target from $2...

 privia-health-gr-affirms-fy2025-sales-guidance-of-180b-190b-vs-322b-est

Privia Health Gr (NASDAQ:PRVA) affirms FY2025 sales outlook from $1.80 billion-$1.90 billion to $1.80 billion-$1.90 billion vs ...

 privia-health-gr-q1-adj-eps-022-beats-005-estimate-sales-48010m-miss-77708m-estimate

Privia Health Gr (NASDAQ:PRVA) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.0...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION